Glucagon Metabolism in Man. Studies on the Metabolic Clearance Rate and the Plasma Acute Disappearance Time of Glucagon in Normal and Diabetic Subjects
Abstract
To investigate further the "hyperglucagonaemia" of diabetes mellitus, the metabolic clearance rate (MCR) and acute disappearance time (t1/2) of unlabelled pancreatic glucagon were estimated in 9 normal subjects and 7 insulin-dependent diabetics, using a constant infusion technique. The mean MCR (+/-SE) was similar for both groups (control: 9.0 +/- 0.6; diabetics: 11.4 +/- 1.0 ml/kg/min). The MCR was not influenced by the concentration of glucagon at the time of plateau, and the exogenous hormone appeared to be handled similarly to endogenous glucagon. On the other hand, t1/2 calculated from the fractional decay rate of glucagon from plateau was significantly prolonged in the diabetics (t1/2 6.6 +/- 0.5 min) compared with the control group (t1/2 4.8 +/- 0.2 min, P less than 0.01). Furthermore, there was no correlation between MCR and t1/2, for the control, diabetic, or combined group. It therefore appears that the MCR of glucagon is similar in normal and diabetic subjects. However, since the acute disappearance time (t1/2) of glucagon is not identical in these two groups, it appears that the kinetics of the overall in vivo metabolism of pancreatic glucagon are not similar in diabetic and control subjects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The optimal parameters reside in the physiological range compared with reported half-life values of 3-6 min and 6.6±0.5 min.
“Compared with the reported information from the pharmaceutical company (3–6 min)20 and the literature (6.6±0.5 min),21 the optimal parameters reside in the physiological range.”
From Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients (2013) · cites this paper as [21]
Cites
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837 · see citing works
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688 · see citing works
Abnormal Alpha-Cell Function in Diabetes: Response to Carbohydrate and Protein Ingestion
Müller, W. A., Faloona, G. R., Aguilar-Parada, E., & Unger, R. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007162830301 · Cited by 626 · see citing works
The essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599 · see citing works
Pancreatic Glucagon Secretion in Normal and Diabetic Subjects
Aguilar-Parada, E., Eisentraut, A. M., & Unger, R. H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00008 · Cited by 538 · see citing works
Glucagon levels and metabolic effects in fasting man
Marliss, E. B., Aoki, T. T., Unger, R. H., Soeldner, J. S., & Cahill, G. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106445 · Cited by 338 · see citing works
The design and analysis of isotope experiments
Zilversmit, D. B. (1960) · The American Journal of Medicine · doi:10.1016/0002-9343(60)90117-0 · Cited by 321 · see citing works
Review: The Use of Isotopic Steroids for the Measurement of Production Rates in Vivo1
Tait, J. F. (1963) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-23-12-1285 · Cited by 274 · see citing works
Effects of Somatostatin on Plasma Glucose and Glucagon Levels in Human Diabetes Mellitus
Gerich, J. E., Lorenzi, M., Schneider, V. B., Karam, J. H., Rivier, J., Guillemin, R., & Forsham, P. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409122911102 · Cited by 238 · see citing works
Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon
Samols, E., Marri, G., & Marks, V. (1966) · Diabetes · doi:10.2337/diab.15.12.855 · Cited by 199 · see citing works
Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic Men
LILJENQUIST, J. E., Bomboy, J. D., Lewis, S. B., SINCLAIR-SMITH, B. C., Felts, P. W., LACY, W. W., Crofford, O. B., & Liddle, G. W. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107537 · Cited by 147 · see citing works
Wilmore, D. W., Moylan, J. A., Pruitt, B., Lindsey, C. A., Faloona, G. R., & Unger, R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92290-9 · Cited by 147 · see citing works
Kohler, P. O., Ross, G. T., & Odell, W. D. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105713 · Cited by 135 · see citing works
Blackard, W. G., Nelson, N. C., & Andrews, S. S. (1974) · Diabetes · doi:10.2337/diab.23.3.199 · Cited by 127 · see citing works
GLUCAGON CONTROL OF FASTING GLUCOSE IN MAN
ALFORD, F. P., Bloom, S. R., Nabarro, J. D. N., Hall, R., BESSER, G. M., Coy, D. H., Kastin, A. J., & Schally, A. V. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92071-6 · Cited by 126 · see citing works
Self-citationThompson, R. G., Rodriguez, A., Kowarski, A. A., & Blizzard, R. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107146 · Cited by 115 · see citing works
Evaluation of Alpha-Cell Function by Infusion of Alanine in Normal, Diabetic and Obese Subjects
Wise, J. K., Hendler, R., & Felig, P. (1973) · New England Journal of Medicine · doi:10.1056/nejm197303082881003 · Cited by 114 · see citing works
Owens, D., Srivastava, M. C., Tompkins, C. V., Nabarro, J. D. N., & Sönksen, P. H. (1973) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1973.tb00353.x · Cited by 105 · see citing works
Self-citationCoble, Y. D., Kohler, P. O., Cargille, C. M., & Ross, G. T. (1969) · Journal of Clinical Investigation · doi:10.1172/jci105992 · Cited by 98 · see citing works
ABNORMALITIES OF GLUCAGON METABOLISM IN UNTREATED DIABETES MELLITUS
Buchanan, K. D., & Mccarroll, A. M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92964-9 · Cited by 97 · see citing works
Solid phase synthesis of growth hormone-release inhibiting factor
Coy, D. H., Coy, E. J., Arimura, A., & Schally, A. V. (1973) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(73)91124-8 · Cited by 89 · see citing works
Insulin delivery rate into plasma in normal and diabetic subjects
D, M. P. S. M., Farquhar, J. W., Silvers, A., & Reaven, G. M. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105884 · Cited by 62 · see citing works
(1973) · PubMed · Cited by 57 · see citing works
Self-citationBerson, S. A., Yalow, R. S., & Volk, B. (1957) · PubMed · Cited by 53 · see citing works
Hedïng, L. G., & Rasmussen, S. M. (1972) · Diabetologia · doi:10.1007/bf01212168 · Cited by 52 · see citing works
Metabolic clearance rate of radioiodinated human growth hormone in man
Cameron, D. P., Burger, H., Catt, K. J., & Doig, A. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106125 · Cited by 45 · see citing works
Relative Influence of Obesity and Diabetes on Plasma Alpha-Cell Glucagon
Gossain, V. V., Matute, M., & Kalkhoff, R. K. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-2-238 · Cited by 33 · see citing works
ABNORMALITIES OF GLUCAGON METABOLISM IN DIABETES MELLITUS
Day, J., & Anderson, J. V. (1973) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1973.tb00422.x · Cited by 30 · see citing works
Glucagon Clearance by the Isolated Perfused Rat Liver
Buchanan, K. D., Solomon, S. S., Vance, J. E., Porter, H. P., & Williams, R. H. (1968) · Experimental Biology and Medicine · doi:10.3181/00379727-128-33081 · Cited by 29 · see citing works
The Secretion Rate of Human Growth Hormone I. Daily Secretion Rates, Effect of Posture and Sleep
ALFORD, F. P., Baker, H. W. G., & Burger, H. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-4-515 · Cited by 25 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419 · see citing works
Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
Habegger, K. M., Stemmer, K., Cheng, C., Müller, T. D., Heppner, K. M., Ottaway, N., Holland, J., Hembree, J. L., Smiley, D., Gelfanov, V., et al. (2013) · Diabetes · doi:10.2337/db12-1116 · Cited by 245 · see citing works
Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes Mellitus
Campbell, P. J., Bolli, G. B., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122302 · Cited by 218 · see citing works
Kinetics of human connecting peptide in normal and diabetic subjects.
Faber, O., Hagen, C., Binder, C., Markussen, J., Naithani, V., Blix, P., Kuzuya, H., Horwitz, D. L., Rubenstein, A., & Rossing, N. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109106 · Cited by 229 · see citing works
2 Intra-islet insulin—glucagon—somatostatin relationships
Samols, E., Bonner‐Weir, S., & Weir, G. C. (1986) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(86)80041-x · Cited by 155 · see citing works
ALFORD, F. P., Bloom, S. R., & Nabarro, J. D. N. (1977) · Diabetologia · doi:10.1007/bf00996319 · Cited by 130 · see citing works
Self-citationThe Mechanism of the Carbohydrate Intolerance of Cirrhosis*
Proietto, J., ALFORD, F. P., & Dudley, F. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-5-1030 · Cited by 124 · see citing works
Self-citationDipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon
Hinke, S. A., Pospisilik, J. A., Demuth, H.-U., Manhart, S., Kühn‐Wache, K., Hoffmann, T., Nishimura, E., Pederson, R. A., & McIntosh, C. H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3827 · Cited by 122 · see citing works
Baldissera, F. G. A., Holst, J. J., Knuhtsen, S., Hilsted, L., & Nielsen, O. V. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90099-7 · Cited by 114 · see citing works
Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis
Bendtsen, F., Schifter, S., & Henriksen, J. H. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90920-7 · Cited by 94 · see citing works
Pontiroli, A. E., Calderara, A., & Pozza, G. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198917050-00001 · Cited by 92 · see citing works
Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
Pospisilik, J. A., Hinke, S. A., Pederson, R. A., Hoffmann, T., Rosche, F., Schlenzig, D., Glund, K., Heiser, U. F., McIntosh, C. H. S., & Demuth, H. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00170-1 · Cited by 70 · see citing works
Hemodynamic Effects of Glucagon: A Literature Review
Petersen, K. M., Bøgevig, S., Holst, J. J., Knop, F. K., & Christensen, M. B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00050 · Cited by 68 · see citing works
Glucagon as a target for the treatment of Type 2 diabetes
Sloop, K. W., Michael, M. D., & Moyers, J. S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.593 · Cited by 64 · see citing works
Hepatic glucagon action: beyond glucose mobilization
Kajani, S., Laker, R. C., Ratkova, E. L., Will, S., & Rhodes, C. J. (2024) · Physiological Reviews · doi:10.1152/physrev.00028.2023 · Cited by 60 · see citing works
HYPERINSULINAEMIA AND INSULIN RESISTANCE OF CIRRHOSIS: THE IMPORTANCE OF INSULIN HYPERSECRETION
Proietto, J., Dudley, F. J., Aitken, P. M., & ALFORD, F. P. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb01408.x · Cited by 44 · see citing works
Self-citationNovel function of transthyretin in pancreatic alpha cells
Su, Y., Jono, H., Misumi, Y., Senokuchi, T., Guo, J., Ueda, M., Shinriki, S., Tasaki, M., Shono, M., Obayashi, K., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.10.025 · Cited by 42 · see citing works
Extrapancreatic Glucagon and Glucagonlike Immunoreactivity in Depancreatized Dogs
Müller, W. A., Girardier, L., Seydoux, J., Berger, M., Renold, A. E., & Vranić, M. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109096 · Cited by 38 · see citing works
Pontiroli, A. E., Calderara, A., Perfetti, M. G., & Bareggi, S. R. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315314 · Cited by 36 · see citing works
AUTOIMMUNITY IN DIABETICS INDUCED BY HORMONAL CONTAMINANTS OF INSULIN
Adrian, T. E., Polak, T. M., Bloom, S. R., & Barnes, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90455-0 · Cited by 35 · see citing works
Self-citationDudley, F. J., ALFORD, F. P., Chisholm, D. J., & Findlay, D. M. (1979) · Gut · doi:10.1136/gut.20.10.817 · Cited by 33 · see citing works
Self-citationCLEARANCE OF EXOGENOUS PARATHYROID HORMONE IN NORMAL AND URAEMIC MAN
Papapoulos, S. E., Hendy, G. N., Tomlinson, S., Lewin, I. G., & O'Riordan, J. L. H. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01317.x · Cited by 32 · see citing works
Pharmacokinetics of Insulin Aspart and Glucagon in Type 1 Diabetes during Closed-Loop Operation
Haidar, A., Duval, C., Legault, L., & RABASA-LHORET, R. P. R. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700610 · Cited by 29 · see citing works
Hinshaw, L., Mallad, A., Man, C. D., Basu, R., Cobelli, C., Carter, R. E., Kudva, Y. C., & Basu, A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00236.2015 · Cited by 28 · see citing works
Gaetano, A. D., & Hardy, T. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222833 · Cited by 29 · see citing works
Wang, Y., Du, J., Zou, H., Liu, Y., Zhang, Y., González, J., Chao, E., Lu, L., Yang, P., Parker, H., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606321 · Cited by 23 · see citing works
The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans
Feo, P. D., Perriello, G., Ventura, M. M., Brunetti, P., Santeusanio, F., Gerich, J. E., & Bolli, G. B. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.4.e565 · Cited by 21 · see citing works
Burman, K. D., Smallridge, R. C., Jones, L. R., RAMOS, E. A., O’Brian, J. T., WRIGHT, F. D., & Wartofsky, L. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-5-1158 · Cited by 21 · see citing works
ALFORD, F. P., Dudley, F. J., Chisholm, D. J., & Findlay, D. M. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb03093.x · Cited by 20 · see citing works
Self-citationMcMurtry, J. P., Tsark, W. M. K., Cogburn, L. A., Rosebrough, R. W., & Brocht, D. M. (1996) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/0742-8413(96)00049-7 · Cited by 19 · see citing works
Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients
Lv, D., Breton, M. D., & Farhy, L. S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0150 · Cited by 17 · see citing works
Glucagon Clearance Is Preserved in Type 2 Diabetes
Grøndahl, M. F. G., Lund, A., Bagger, J. I., Petersen, T. S., Albrechtsen, N. J. W., Holst, J. J., Vilsbøll, T., Christensen, M., & Knop, F. K. (2021) · Diabetes · doi:10.2337/db21-0024 · Cited by 17 · see citing works
Jaspan, J. B., Polonsky, K. S., Lewis, M., Pensler, J., Pugh, W., Moossa, A. R., & Rubenstein, A. H. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.3.e233 · Cited by 68 · see citing works
Laker, R. C., Egolf, S., Will, S., Lantier, L., McGuinness, O. P., Brown, C. L., Bhagroo, N. V., Oldham, S. N., Kuszpit, K. K., Alfaro, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59773-4 · Cited by 13 · see citing works
The Metabolic Clearance Rate of Glucagon
Polonsky, K. S., Jaspan, J. B., & Rubenstein, A. H. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_17 · Cited by 12 · see citing works
Sensitive Glucagon Quantification by Immunochemical and LC–MS/MS Methods
Lapko, V. N., Miller, P. S., Brown, G. P., Islam, M. R., Peters, S. K., Sukovaty, R. L., Ruhn, P. F., & Kafonek, C. J. (2013) · Bioanalysis · doi:10.4155/bio.13.264 · Cited by 11 · see citing works
DPIV — Natural Substrates of Medical Importance
Meester, I. D., Durinx, C., Proost, P., Scharpé, S., & Lambier, A.-M. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0619-5_9 · Cited by 10 · see citing works
Renuse, S., Benson, L. M., Vanderboom, P. M., RUCHI, F., YADAV, Y. R., Johnson, K. L., Brown, B. C., Peterson, J. A., Basu, R., McCormick, D., et al. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09344-2 · Cited by 9 · see citing works
A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
Subramanian, V., Bagger, J. I., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.911616 · Cited by 9 · see citing works
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy
Prato, S. D., de Kreutzenberg, S. V., Trevisan, R., Duner, E., Avogaro, A., Nosadini, R., Baccaglini, U., Tremolada, C., & Tiengo, A. (1985) · Diabetologia · doi:10.1007/bf00271685 · Cited by 8 · see citing works
Glucagon kinetics in growing rats fed different levels of protein and/or energy
Balage, M., Grizard, J., HOULIER, M.-L., BONNET, Y., SALLAS, M., & Selle, A. (1984) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:19840305 · Cited by 8 · see citing works
Huang, C., Wille, C. B., He, H., Reddy, V., Nargund, R. P., Lin, S., & Palani, A. (2017) · Tetrahedron Letters · doi:10.1016/j.tetlet.2017.02.031 · Cited by 7 · see citing works
Rates of Removal of Exogenous and Endogenous Glucagon From the Plasma of Sheep in Vivo
Brockman, R. P. (1980) · Australian Journal of Biological Sciences · doi:10.1071/bi9800531 · Cited by 7 · see citing works
Howard, J. W., Kay, R. G., Tan, T., MINNION, J. S., & Creaser, C. S. (2014) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7090 · Cited by 6 · see citing works
Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects
Faggionato, E., LAURENTI, M. C., Vella, A. V., & Man, C. D. (2023) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2023.3262974 · Cited by 5 · see citing works
Stability, toxicity and biological activity of retro, inversed and retro‐inversed glucagon isomers
Krasniqi, B., Scruten, E., Piller, J., Lee, J., & Napper, S. (2012) · Journal of Peptide Science · doi:10.1002/psc.2429 · Cited by 5 · see citing works
Anaesthetic management of glucagonoma
Nicoll, J. M. V., & Catling, S. (1985) · Anaesthesia · doi:10.1111/j.1365-2044.1985.tb10706.x · Cited by 5 · see citing works
Glucagon—New Concepts About an “Old” Hormone
ALFORD, F. P., & Chisholm, D. J. (1979) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1979.tb04210.x · Cited by 5 · see citing works
Self-citationPek, S. (1977) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(77)80041-8 · Cited by 5 · see citing works
THE METABOLIC EFFECTS OF CHRONIC HYPERGLUCAGONAEMIA
Nankervis, A. J., Proietto, J., Ng, K. W., ALFORD, F. P., & Larkins, R. G. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00672.x · Cited by 5 · see citing works
Self-citationWang, Y., Du, J., Zou, H., Liu, Y., Zhang, Y., González, J., Chao, E., Lu, L., Yang, P., Parker, H., et al. (2016) · Angewandte Chemie · doi:10.1002/ange.201606321 · Cited by 4 · see citing works
Proportional Insulin Infusion in Closed-Loop Control of Blood Glucose
Grasman, J., Callender, H. L., & Mensink, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169135 · Cited by 4 · see citing works
Glucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 4 · see citing works
Circulating Glucagon Components: Significance in Health and Disease
Jaspan, J. B., Huen, A. H.-J., Gonen, B., & Rubenstein, A. H. (1977) · Springer eBooks · doi:10.1007/978-1-4612-6366-1_7 · Cited by 4 · see citing works
Glucagon and tolbutamide as insulin secretagogues in the pig (Sus domesticus)
Richardson, R., & Weekes, T. E. C. (1982) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(82)90172-4 · Cited by 3 · see citing works
Contrainsulin Hormones: Biochemical and Physiological Aspects
Gerich, J. E., & Cryer, P. E. (1991) · Springer eBooks · doi:10.1007/978-1-4684-0400-5_6 · Cited by 3 · see citing works
Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes
RUCHI, F., Schiavon, M., Pandey, A., Man, C. D., Cobelli, C., Basu, R., & Basu, A. (2025) · Diabetes · doi:10.2337/db25-0587 · Cited by 2 · see citing works
RUCHI, F., Schiavon, M., YADAV, Y. R., Man, C. D., Cobelli, C., Pandey, A., Wilkins, L. R., Basu, R., & Basu, A. (2025) · Diabetes · doi:10.2337/db24-1064 · Cited by 2 · see citing works
Postprandial mesenteric blood flow.
Braatvedt, G. D., Read, A. E., Corrall, R. J. M., Halliwell, M., & Wells, P. N. T. (1991) · Gut · doi:10.1136/gut.32.11.1428 · Cited by 1 · see citing works
Hormone metabolism in the pulmonary circulation
Aliberti, G., Pulignano, I., Proietta, M., Miraldi, F., Cigognetti, L., Tritapepe, L., Giovanni, C. D., Arzilla, R., Vecci, E., & Toscano, M. (2001) · Physiological Research · doi:10.33549/physiolres.930027 · Cited by 1 · see citing works
Phase 1 Study of Glucagon (GL-G) Produced by Genetic Engineering Technology.
Urae, A., Irie, S., MAKINO, K., Amamoto, T., 森瀬, 春., Sakata, Y., & Urae, R. (1991) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.22.451 · Cited by 1 · see citing works
Counterregulatory Hormones: Molecular, Biochemical, and Physiologic Aspects
Gerich, J. E., & Cryer, P. E. (1998) · Springer eBooks · doi:10.1007/978-1-4612-1642-1_9 · Cited by 1 · see citing works
Immunological specificity and biological action of biliary glucagon-like substance in the rabbit.
Kondo, M. (1983) · Endocrinologia Japonica · doi:10.1507/endocrj1954.30.235
Maxwell, G. M. (1984) · Springer eBooks · doi:10.1007/978-1-4684-7544-9_13
Fast-to-fed shift in glucose homeostasis: clues to an earlier detection of human prediabetic states
Patarrão, R. S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Leen, J. (2010) · TSpace (University of Toronto)
Chronic Hyperglycemia—A Primer
Fried, R., & Carlton, R. M. (2018) · CRC Press eBooks · doi:10.1201/9780429507250-1
Assal, J. ‐., & Froesch, E. R. (1986) · Springer eBooks · doi:10.1007/978-3-642-70509-0_13
グルカゴン1.0, 0.1, 0.01 mg筋注時のヒト血糖およびインスリン反応の比較
奥野, 巍., 基, 多., 煕, 福., 勝彦, 岡., 魁, 柏., 秀夫, 竹., & 健二, 島. (1977) · 糖尿病 · doi:10.11213/tonyobyo1958.20.574
Li, X., Wang, Y., Chen, Z., & Tan, Z. (2025) · ChemBioChem · doi:10.1002/cbic.202500270
Glucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/j.2040-4603.2001.tb01454.x
Renuse, S., Benson, L. M., Vanderboom, P. M., RUCHI, F., Yadav, Y. R., Johnson, K. L., Brown, B. C., Peterson, J. A., Basu, R., McCormick, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802413
Dalton, M., Asante-Asamani, E. O., & Greene, J. M. (2026) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2026060
- Authors
- ALFORD, F. P., BLOOM, S. R., & NABARRo, J. D. N.
- ORCID
- BLOOM, S. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1976-05
- Volume
- 42
- Issue
- 5
- Pages
- 830-838
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2044346387
- Cited by
- 74
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metabolic clearance rate, hyperglucagonaemia, diabetes mellitus, type 1 diabetes, pancreatic glucagon
- MeSH terms
- Adolescent, Adult, Clinical Trials as Topic, Diabetes Mellitus, Female, Glucagon, Humans, Male, Metabolic Clearance Rate, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review